EPS for TransDigm Group Incorporated (TDG) Expected At $2.61

Lloyd Doyle
January 13, 2018

Stifel Financial Corp now owns 4,419 shares of the aerospace company's stock worth $1,138,000 after acquiring an additional 673 shares in the last quarter. 388,220 shares of the company's stock traded hands, compared to its average volume of 464,511.

Cubist Systematic Strategies LLC bought a new position in shares of TransDigm Group Incorporated (NYSE:TDG) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).

Eam Investors Llc decreased its stake in Paratek Pharmaceuticals Inc.

Ensemble Capital Management Llc, which manages about $381.11M and $477.10 million US Long portfolio, upped its stake in Now Inc (NYSE:DNOW) by 438,000 shares to 1.73 million shares, valued at $23.89 million in 2017Q3, according to the filing. The firm bought 2,437 shares of the aerospace company's stock, valued at approximately $623,000. The hedge fund held 158,414 shares of the consumer services company at the end of 2017Q3, valued at $25.91 million, up from 153,589 at the end of the previous reported quarter. Poplar Forest Capital Llc who had been investing in Weatherford Intl Plc for a number of months, seems to be bullish on the $4.14 billion market cap company.

Shares of TransDigm Group (NYSE:TDG) traded up $4.99 during mid-day trading on Friday, reaching $292.50. Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) has risen 62.03% since January 12, 2017 and is uptrending. It has outperformed by 3.62% the S&P500.

Investors sentiment increased to 0.93 in 2017 Q3. Its up 0.30, from 0.63 in 2017Q2. It improved, as 30 investors sold TDG shares while 129 reduced holdings. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in shares of TransDigm Group by 13.3% during the second quarter. Navellier And owns 0.09% invested in TransDigm Group Incorporated (NYSE:TDG) for 1,775 shares. Rafferty Asset Mngmt Llc stated it has 0.02% in TransDigm Group Incorporated (NYSE:TDG). The aerospace company reported $3.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.18 by $0.30.

Among 19 analysts covering Transdigm Group Incorporated (NYSE:TDG), 10 have Buy rating, 2 Sell and 7 Hold. Exxonmobil Invest Mngmt Tx has 8,816 shares. (NYSE:HD). Lyons Wealth accumulated 5,208 shares. Df Dent & Inc owns 237,330 shares or 1.57% of their United States portfolio. 796.24 million shares or 3.15% less from 822.13 million shares in 2017Q2 were reported. Vantage Advisors Ltd Liability owns 355 shares or 0.02% of their USA portfolio. Bessemer, New Jersey-based fund reported 2,338 shares. Federated Pa has 7,371 shares for 0.01% of their portfolio. Profund Llc holds 1,334 shares. Morgan Stanley holds 0.22% of its portfolio in TransDigm Group Incorporated (NYSE:TDG) for 2.92 million shares.

Since August 15, 2017, it had 0 insider buys, and 4 sales for $8.73 million activity. 229,716 shares were sold by Simons James R. The stock of TransDigm Group Incorporated (NYSE:TDG) earned "Outperform" rating by Wolfe Research on Friday, November 20. Therefore 53% are positive. TransDigm Group Incorporated has a fifty-two week low of $203.72 and a fifty-two week high of $295.00. As per Wednesday, June 21, the company rating was maintained by RBC Capital Markets. The firm has a market capitalization of $14,940.00, a price-to-earnings ratio of 34.02, a P/E/G ratio of 2.31 and a beta of 0.62. As per Friday, September 1, the company rating was maintained by RBC Capital Markets. The rating was maintained by Cowen & Co on Monday, July 17 with "Hold". Also, CEO W Nicholas Howley sold 63,776 shares of the company's stock in a transaction on Thursday, November 16th. On Monday, November 23 the stock rating was maintained by Canaccord Genuity with "Buy".

TransDigm Group (NYSE:TDG) last released its quarterly earnings data on Thursday, November 9th. Jefferies maintained it with "Buy" rating and $322.0 target in Tuesday, September 5 report.

Analysts await Paratek Pharmaceuticals, Inc. 1,516 were reported by Garde Cap Inc. They expect $2.61 earnings per share, up 6.53% or $0.16 from last year's $2.45 per share. The aerospace company reported $3.48 EPS for the quarter, topping analysts' consensus estimates of $3.18 by $0.30.

Investors sentiment decreased to 1.54 in Q3 2017. 20 funds opened positions while 35 raised stakes. The firm has "Buy" rating given on Friday, March 11 by Goldman Sachs. Insiders own 10.52% of the company's stock. Franklin Res invested in 0% or 1,777 shares. Moreover, Voya Invest Limited Com has 0% invested in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK). Sei Com holds 0% in Paratek Pharmaceuticals, Inc. Metropolitan Life Insurance New York accumulated 24,976 shares. Wells Fargo And Co Mn owns 16,825 shares for 0% of their portfolio. Tru Department Mb Natl Bank N A holds 64,398 shares or 1.13% of its portfolio. Rock Springs Cap Lp reported 0.52% in Paratek Pharmaceuticals, Inc. Fifth Third Bancorporation reported 0% stake. 440,626 are held by Cushing Asset Ltd Partnership. Royal Retail Bank Of Canada invested 0% of its portfolio in QuinStreet, Inc. Compton Cap Management Ri holds 10,373 shares. Renaissance Technology holds 0.02% or 3.14M shares in its portfolio.

Hartwell J M Limited Partnership increased its stake in Home Depot Inc. It also reduced its holding in Ishares Tr (IBB) by 7,500 shares in the quarter, leaving it with 7,500 shares, and cut its stake in Spdr Gold Trust (GLD).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article